Verus Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Verus Capital Partners's LLY Position: Q2 2026 in Review
Verus Capital Partners increased its Eli Lilly (LLY) stake by 41% in Q2 2026, buying an estimated $398K and bringing the position to 1,346 shares worth $1.61M. The position accounts for 0.09% of the portfolio, ranked #144.
Verus Capital Partners first reported a position in LLY in Q4 2019 and has held it in 20 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Verus Capital Partners held 1,346 shares of Eli Lilly worth $1.61M as of Q2 2026.
- Verus Capital Partners bought 390 Eli Lilly shares in Q2 2026, an estimated $398K.
- Eli Lilly made up 0.09% of Verus Capital Partners's portfolio in Q2 2026, its #144 holding.
- Verus Capital Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 20 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Verus Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.